Cargando…
Exosomes Treatment Mitigates Ischemic Brain Damage but Does Not Improve Post-Stroke Neurological Outcome
BACKGROUND/AIMS: Recent studies demonstrated that the treatment with mesenchymal stem cells (MSCs) obtained from the human umbilical cord blood improved survival, reduced brain damage, prevented apoptosis, suppressed inflammatory responses, downregulated the DNA damage-inducing genes, upregulated th...
Autores principales: | Nalamolu, Koteswara Rao, Venkatesh, Ishwarya, Mohandass, Adithya, Klopfenstein, Jeffrey D., Pinson, David M., Wang, David Z., Veeravalli, Krishna Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996798/ https://www.ncbi.nlm.nih.gov/pubmed/31026391 http://dx.doi.org/10.33594/000000090 |
Ejemplares similares
-
Post-stroke mRNA expression profile of MMPs: effect of genetic deletion of MMP-12
por: Nalamolu, Koteswara Rao, et al.
Publicado: (2018) -
Stem cell treatment improves post stroke neurological outcomes: a comparative study in male and female rats
por: Nalamolu, Koteswara Rao, et al.
Publicado: (2021) -
Therapeutic efficacy of matrix metalloproteinase-12 suppression on neurological recovery after ischemic stroke: Optimal treatment timing and duration
por: Challa, Siva Reddy, et al.
Publicado: (2022) -
Post-transcriptional inactivation of matrix metalloproteinase-12 after focal cerebral ischemia attenuates brain damage
por: Chelluboina, Bharath, et al.
Publicado: (2015) -
Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats
por: Rao, Nalamolu Koteswara, et al.
Publicado: (2006)